Dr. Janet E. McElhaney

  • Dr. Janet E. McElhaney currently holds the positions of Associate Professor of Medicine, Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine (since 2003); Director, Clinical Research Interdisciplinary Scholars Program (since 2003); and Advisor to the ESWI Scientific Committee (since 2002). She is a Fellow of the Royal College of Physicians and Surgeons of Canada (since 1990); Fellow of the American College of Physicians (since 2002); Certified Medical Director in Long Term Health Care; and is board certified in Internal Medicine and Geriatric Medicine in both Canada (since 1991) and the United States (since 1992).
  • Dr. McElhaney studied at the University of Alberta, Faculty of Medicine from 1982 to 1986 and received her MD degree with honours. She completed her residency in Internal Medicine from 1986-1989 and her Fellowship in geriatric medicine from 1989-1991 at the University of Alberta, Faculty of Medicine. From 1991 to 1998, she was a member of the Faculty at the University of Alberta where she held a number of positions related to her research and geriatric medicine at the University of Alberta Hospital. She was recruited as Associate Professor of Medicine for the Eastern Virginia Medical School in 1998, became Director, Office of Research and Faculty Development, Department of Internal Medicine, Eastern Virginia Medical School in 2000, and completed the Hedwin van Ameringen Executive Leadership in Academic Medicine Programme (from 2001-2002).
  • Dr. McElhaney is also a member of professional societies including the American College of Physicians, American Geriatrics Society, Gerontological Society of America, American Association of Immunologists, American Society of Microbiology, Canadian Society for Geriatric Medicine and the Society for Executive Leadership in Academic Medicine.
  • She holds an editorial appointment and has served as a reviewer for a number of scientific publications and has been a scientific adviser to pharmaceutical companies. She is a winner of numerous scientific awards. She has received research funding in both Canada and the United States and currently has funding from the National Institute on Aging as part of the National Institutes of Health. The focus is translational research as it applies to immunogerontological studies of the immune response to influenza and influenza vaccination, and is widely published in this area as well as other aspects of geriatric medicine. She has been a research mentor to numerous graduate students and junior faculty members in many fields of healthcare.